P-wave dispersion (PWD) is a new electrocardiographic marker that has been associated with inhomogeneous and discontinuous propagation of sinus impulses. 1 Dilaveris P.E Gialafos E.J Andrikopoulos G.K Richter D.J Papanikolaou V Poralis K Gialafos J.E Clinical and electrocardiographic predictors of recurrent atrial fibrillation. Pacing Clin Electrophysiol. 2000; 23: 352-358 Crossref PubMed Scopus (201) Google Scholar , 2 Dilaveris P.E Gialafos E.J Sideris S Theopistou A.M Andrikopoulos G.K Kyriakidis M Gialafos J.E Toutouzas P.K Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J. 1998; 135: 733-738 Abstract Full Text Full Text PDF PubMed Scopus (570) Google Scholar It can be defined as the difference between maximum and minimum P-wave duration. The prolongation of intra-atrial and interatrial conduction time, and the inhomogeneous propagation of sinus impulses are well known electrophysiologic characteristics of the atrium prone to fibrillate. 1 Dilaveris P.E Gialafos E.J Andrikopoulos G.K Richter D.J Papanikolaou V Poralis K Gialafos J.E Clinical and electrocardiographic predictors of recurrent atrial fibrillation. Pacing Clin Electrophysiol. 2000; 23: 352-358 Crossref PubMed Scopus (201) Google Scholar , 2 Dilaveris P.E Gialafos E.J Sideris S Theopistou A.M Andrikopoulos G.K Kyriakidis M Gialafos J.E Toutouzas P.K Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J. 1998; 135: 733-738 Abstract Full Text Full Text PDF PubMed Scopus (570) Google Scholar Furthermore, prolonged P-wave duration and increased PWD have been reported to carry an increased risk for atrial fibrillation (AF). 2 Dilaveris P.E Gialafos E.J Sideris S Theopistou A.M Andrikopoulos G.K Kyriakidis M Gialafos J.E Toutouzas P.K Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J. 1998; 135: 733-738 Abstract Full Text Full Text PDF PubMed Scopus (570) Google Scholar , 3 Aytemir K Ozer N Atalar E Sade E Aksoyek S Ovunc K Oto A Ozmen F Kes S P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2000; 23: 1109-1112 Crossref PubMed Scopus (244) Google Scholar Rheumatic mitral stenosis (MS) is frequently seen in developing countries and causes significant morbidity and mortality. 4 Braunwald E Valvular heart disease. in: Braunwald E Zipes D.P Libby P Heart Disease A Textbook of Cardiovascular Medicine. 6th ed. WB Saunders, Philadelphia2001: 1643-1653 Google Scholar Percutaneous mitral balloon valvuloplasty (PMBV) is the procedure of choice in patients who have symptomatic, hemodynamically severe MS, and are suitable for this procedure. 4 Braunwald E Valvular heart disease. in: Braunwald E Zipes D.P Libby P Heart Disease A Textbook of Cardiovascular Medicine. 6th ed. WB Saunders, Philadelphia2001: 1643-1653 Google Scholar , 5 Inoue K Owaki T Nakamura T Kitamura F Miyamoto N Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg. 1984; 87: 394-402 PubMed Google Scholar , 6 Reyes V.P Raju B.S Wynne J Stephenson L.W Raju R Fromm B.S Rajagopal P Mehta P Singh S Rao D.P Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N Engl J Med. 1994; 331: 961-967 Crossref PubMed Scopus (344) Google Scholar This procedure is highly successful with a low complication rate and significant short- and long-term improvement in hemodynamics and symptoms. 7 McKay C.R Kawanishi D.T Kotlewski A Parise K Odom-Maryon T Gonzalez A Reid C.L Rahimtoola S.H Improvement in exercise capacity and exercise hemodynamics 3 months after double-balloon, catheter balloon valvuloplasty treatment of patients with symptomatic mitral stenosis. Circulation. 1988; 77: 1013-1024 Crossref PubMed Scopus (80) Google Scholar , 8 Block P.C Palacios I.F Block E.H Tuzcu E.M Griffin B Late (two-year) follow-up after percutaneous balloon mitral valvotomy. Am J Cardiol. 1992; 69: 537-541 Abstract Full Text PDF PubMed Scopus (50) Google Scholar The objectives of this study were (1) to identify PWD in patients with MS, and (2) to determine the effects of PMBV on PWD. There is currently no study on the effects of MS and PMBV on PWD.
Read full abstract